Molecule2Market (M2M) is an expert clinical research team advancing medical innovations in Australia and the Asia Pacific region, providing high-quality contract services to pharmaceutical and biotech industries.

M2M specialises in medical device and diagnostic trials, from pilot through to pivotal. We design studies tailored to your regulatory and commercial goals, and with Australia’s fast approvals and strong investigator networks, we get you to data quicker. Our hand-picked team combines deep expertise with a collaborative approach - giving you a partner who’s committed to your success.

Why work with us

Why M2M?

• Specialised expertise – We have deep experience in both medical device and diagnostics trials, understanding the unique regulatory, technical, and operational challenges that differ from drug studies.
• Proven track record – Our team has successfully delivered both pilot and pivotal studies across multiple platforms, helping clients generate the evidence needed for approvals and market adoption.
• Tailored approach – We don’t take a one-size-fits-all approach. We conduct studies to match your device’s development stage, regulatory pathway, and commercial goals.
• Speed and efficiency – Based in Australia, we offer rapid ethics and regulatory approvals, streamlined recruitment pathways, and access to world-class investigators - getting you to data faster.
• Trusted relationships – Each member of our team has been carefully chosen for their ability to combine technical expertise with a collaborative, people-first culture. That means you get a partner who understands the science, the strategy, and your business needs.